You are here: Home » Archives for board of directors

eXp Realty Taps Real Estate Veteran Bryon Ellington To Revolutionize Agent-Driven Learning

BELLINGHAM, Wash., Oct. 03, 2023 (GLOBE NEWSWIRE) — eXp Realty , "the most agent–centric real estate brokerage on the planet" and the core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), today announced the appointment of Bryon Ellington as Chief Learning Officer, responsible for developing custom, agent–driven training and coaching.

Ellington, a seasoned professional with more than 20 years of experience in real estate and coaching, brings a wealth of knowledge and expertise to eXp Realty. He will focus on developing agent–driven training at every level, setting a new standard for success in the real estate industry.

"Bryon's dedication to agent success aligns perfectly with our values, and he excels at driving growth and new revenue streams," said Glenn Sanford, Founder and CEO of eXp Realty. "Under his leadership, eXp Realty will become the leading brokerage in training, with a focus on delivering the best education and resources to help our agents excel. Throughout his career, Bryon has helped numerous agents achieve incredible accolades, increase productivity metrics and grow their businesses."

Ellington's passion is helping entrepreneurs in the real estate space build businesses beyond their dreams. "I am excited to join the eXp Realty team and contribute to its mission of empowering agents to reach their full potential," he said. "Whether you are a new agent or lead a massive team, with eXp you can continue to grow your business to exceed your goals."

Ellington's impressive tenure includes notable executive roles most recently as Chief Operating Officer and Chief Development Officer at Century 21. He also held positions at Keller Williams, as Chief Product Officer and Chief Operating Officer of the KW Worldwide International Franchising division. Additionally, he served as Chief Learning Officer, where his achievements earned him the distinction of winning the Training magazine T125 Top Training Companies award for four consecutive years and induction into the Hall of Fame.

Earlier in his career, at Anywhere (Realogy), he successfully created and led the training and coaching divisions for all their franchise brands and company–owned operations.

About eXp World Holdings, Inc.
eXp World Holdings, Inc. (Nasdaq: EXPI) is the holding company for eXp Realty , Virbela and SUCCESS Enterprises.

eXp Realty is the largest independent real estate company in the world with more than 89,000 agents in the United States, Canada, the United Kingdom, Australia, South Africa, India, Mexico, Portugal, France, Puerto Rico, Brazil, Italy, Hong Kong, Colombia, Spain, Israel, Panama, Germany, Dominican Republic, Greece, New Zealand, Chile, Poland and Dubai and continues to scale internationally. As a publicly traded company, eXp World Holdings provides real estate professionals the unique opportunity to earn equity awards for production goals and contributions to overall company growth. eXp World Holdings and its businesses offer a full suite of brokerage and real estate tech solutions, including its innovative residential and commercial brokerage model, professional services, collaborative tools and personal development. The cloud–based brokerage is powered by Virbela, an immersive 3D platform that is deeply social and collaborative, enabling agents to be more connected and productive. SUCCESS Enterprises, anchored by SUCCESS magazine and its related media properties, was established in 1897 and is a leading personal and professional development brand and publication.

For more information, visit https://expworldholdings.com.

Safe Harbor Statement

The statements contained herein may include statements of future expectations and other forward–looking statements that are based on management's current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Such forward–looking statements speak only as of the date hereof, and the company undertakes no obligation to revise or update them. Such statements are not guarantees of future performance. Important factors that may cause actual results to differ materially and adversely from those expressed in forward–looking statements include changes in business or other market conditions; the difficulty of keeping expense growth at modest levels while increasing revenues; and other risks detailed from time to time in the company's Securities and Exchange Commission filings, including but not limited to the most recently filed Quarterly Report on Form 10–Q and Annual Report on Form 10–K.

Media Relations Contact:

eXp World Holdings, Inc.

[email protected]

Investor Relations Contact:

Denise Garcia

[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ba1c70f4–dd70–43ad–b440–7b1197f7200d


GLOBENEWSWIRE (Distribution ID 8942516)

A Quantexa nomeia personalidades conhecidas do setor para o seu Conselho Consultivo para acelerar os planos de crescimento

LONDRES, Sept. 25, 2023 (GLOBE NEWSWIRE) — A Quantexa, lder global em solues de Inteligncia de deciso (DI) para os setores pblico e privado, anunciou hoje que nomeou trs personalidades do setor para o seu Conselho Consultivo. Estas contrataes incluem Ralph Schlosstein, antigo diretor executivo da Evercore e antigo presidente da BlackRock, Matthew Gould, antigo diretor executivo da NHSX, e Sir Jeremy Fleming, antigo diretor do GCHQ. Estes lderes de renome trazem para a Quantexa uma vasta experincia em finanas, cuidados de sade e segurana nacional.

A expanso do Conselho Consultivo da Quantexa ocorre num momento crucial para a organizao, aps a concluso de uma ronda de financiamento da Srie E de 129 milhes de dlares, liderada pelo GIC, em que a Quantexa se juntou a um grupo de elite de empresas tecnolgicas do Reino Unido que alcanaram o estatuto de unicrnio. Foi tambm anunciado este ano que a Quantexa ir investir mais de 155 milhes de dlares na indstria global de IA durante os prximos trs anos para ajudar os clientes a avanar na utilizao da IA para proteger, otimizar e expandir as suas organizaes. At 2027, o investimento global total da Quantexa em IA atingir mais de 250 milhes de dlares.

Ralph Schlosstein, antigo Diretor Executivo da Evercore e antigo Presidente da BlackRock, traz dcadas de experincia em banca de investimento para o Conselho Consultivo da Quantexa. A sua carreira de sucesso inclui o desempenho de um papel estratgico ao ajudar a maior empresa de gesto de ativos do mundo a tornar–se pblica. A perspiccia financeira de Ralph desempenhar um papel fundamental na definio das iniciativas estratgicas da empresa.

Matthew Gould, ex–diretor executivo da NHSX, junta–se ao Conselho Consultivo da Quantexa, depois de ter sido embaixador britnico em Israel entre 2010 e 2015, onde Gould ajudou a lanar o UK–Israel Technologies Hub – uma iniciativa gerida em Telavive para criar parcerias tecnolgicas entre empresas britnicas e israelitas. Mais recentemente, Matthew aproveitou a sua vasta experincia em cuidados de sade para desempenhar um papel fundamental no aconselhamento ao NHS sobre iniciativas durante a pandemia de Covid–19. Na NHSX, Gould foi responsvel por aproveitar o poder dos dados e da tecnologia para melhorar a prestao de cuidados de sade. Os conhecimentos profundos de Matthew ajudaro a Quantexa a identificar as economias e os setores que merecem uma ateno estratgica e a tomar decises sobre a estratgia comercial.

Sir Jeremy Fleming, antigo diretor do GCHQ e antigo diretor–adjunto do MI5, junta–se ao Conselho Consultivo com mais de 30 anos de experincia em servios secretos e tecnologia. A sua vasta experincia inclui o desenvolvimento do National Cyber Security Centre, onde se esforou por tornar o Reino Unido o local mais seguro para viver e fazer negcios online. Apaixonado por tornar mais transparente a utilizao da tecnologia na administrao pblica, Sir Fleming reforar as capacidades da Quantexa para fazer face s ameaas e oportunidades emergentes.

“Temos o prazer de acolher Ralph Schlosstein, Matthew Gould e Sir Jeremy Fleming no nosso Conselho Consultivo”. afirmou Vishal Marria, Diretor Executivo da Quantexa. “O seu conhecimento tcnico coletivo em finanas, sade e segurana nacional ser fundamental para continuarmos a desenvolver solues de inteligncia de deciso inovadoras que atendam s necessidades em evoluo do mercado.”

“A tecnologia ativada por IA da Quantexa permite que os seus clientes protejam, otimizem e desenvolvam as suas organizaes com eficincia e transparncia” afirmou Ralph Schlosstein, antigo diretor executivo da Evercore e antigo presidente da BlackRock. "Acredito que a Quantexa est bem posicionada para aproveitar as oportunidades que se avizinham e aumentar a sua quota na categoria emergente de Inteligncia de Deciso. Estou ansioso por apoiar a equipa executiva no seu trabalho de acelerao da sua estratgia de crescimento orgnico e inorgnico."

” uma altura muito interessante para eu me juntar ao Conselho Consultivo da Quantexa, nesta fase crtica de crescimento da empresa”,disse Matthew Gould. “A abordagem inovadora da Quantexa para ajudar os clientes dos setores pblico e privado a fazer dos dados a sua utilidade mais valiosa est a revolucionar a tomada de decises em vrios setores. Estou ansioso por trabalhar com a talentosa equipa da Quantexa para interligar dados e obter melhores resultados para as organizaes.”

Sir Jeremy Fleming, antigo diretor do GCHQ, comentou “Estou entusiasmado por fazer parte de uma empresa na vanguarda da inovao da IA. Estou ansioso por combinar a minha experincia com as impressionantes capacidades da Quantexa, que continuaro a moldar a forma como os seus clientes utilizam os dados para proteger as empresas e os cidados.”

Com a ajuda do seu Conselho Consultivo, a Quantexa continua dedicada em capacitar as organizaes a tomarem decises operacionais fiveis atravs de solues inovadoras de Inteligncia de Deciso. Para mais informaes sobre a equipa de liderana da Quantexa, clique aqui.

Sobre a Quantexa"

A Quantexa uma empresa global de software de dados e anlise, pioneira na Inteligncia de Deciso que permite s organizaes tomar decises operacionais fiveis, tornando os dados significativos. Utilizando os mais recentes avanos em big data e IA, a Decision Intelligence Platform da Quantexa revela riscos ocultos e novas oportunidades, fornecendo uma viso contextual e conectada de dados internos e externos num nico local. Resolve os maiores desafios em toda a gesto de dados, KYC, informaes do cliente, crime financeiro, risco, fraude e segurana, ao longo do ciclo de vida do cliente.

A Decision Intelligence Platform da Quantexa melhora o desempenho operacional com mais de 90% de preciso e uma resoluo de modelos analticos 60 vezes mais rpida do que as abordagens tradicionais. Fundada em 2016, a Quantexa tem atualmente mais de 650 funcionrios e milhares de utilizadores que trabalham com milhares de milhes de transaes e pontos de informao em todo o mundo. A empresa tem escritrios em Londres, Dublin, Nova Iorque, Boston, Washington DC, Toronto, Emirados rabes Unidos, Mlaga, Amesterdo, Luxemburgo, Bruxelas, Melbourne, Sydney e Singapura. Para mais informaes, siga–nos no LinkedIn.

Contacto para os meios de comunicao social:
C: Stephanie Crisp, Diretora–Adjuta e Estratega de Meios de Comunicao, Fight or Flight""
E: [email protected]""
"
C: Adam Jaffe, VPS de Marketing Empresarial""
T: +1 609 502 6889""
E: [email protected]""


GLOBENEWSWIRE (Distribution ID 1000841125)

Quantexa nomme de grands noms du secteur à son comité consultatif pour accélérer ses plans de croissance

LONDRES, 25 sept. 2023 (GLOBE NEWSWIRE) — Quantexa, leader mondial des solutions d'intelligence dcisionnelle pour les secteurs priv et public, a annonc aujourd'hui la nomination de trois grands noms du secteur au sein de son comit consultatif. Il s'agit de Ralph Schlosstein, ancien PDG d'Evercore et ancien prsident de BlackRock, Matthew Gould, ancien PDG de NHSX, et Sir Jeremy Fleming, ancien directeur du GCHQ. Ces leaders de renom apporteront Quantexa leur prcieuse exprience dans les domaines de la finance, des soins de sant et de la scurit nationale.

L'largissement du comit consultatif de Quantexa survient un moment crucial pour la socit, puisqu'elle a achev un cycle de financement de srie E de 129 millions de dollars, men par GIC, au cours duquel Quantexa a rejoint un groupe privilgi d'entreprises technologiques britanniques sur le point de devenir des licornes. Il a galement t annonc cette anne que Quantexa investira plus de 155 millions de dollars dans le secteur mondial de l'IA au cours des trois prochaines annes afin d'aider les clients promouvoir l'utilisation de l'IA pour protger, optimiser et dvelopper leurs organisations. D'ici 2027, l'investissement mondial total de Quantexa dans l'IA atteindra plus de 250 millions de dollars.

Ralph Schlosstein, ancien PDG d'Evercore et ancien prsident de BlackRock, apportera au comit consultatif de Quantexa ses dcennies d'exprience dans le domaine des investissements bancaires. Au cours de sa carrire, il a notamment jou un rle stratgique dans l'introduction en bourse de la plus grande socit de gestion d'actifs au monde. La perspicacit financire de Ralph Schlosstein sera dterminante pour l'laboration des initiatives stratgiques de l'entreprise.

Matthew Gould, ancien PDG de NHSX, rejoint le comit consultatif de Quantexa aprs avoir t ambassadeur britannique en Isral entre 2010 et 2015, o il a contribu au lancement du UK–Israel Technologies Hub, une initiative mene Tel–Aviv visant forger des partenariats technologiques entre des entreprises britanniques et israliennes. Plus rcemment, Matthew Gould a mis profit sa vaste exprience dans le domaine des soins de sant pour conseiller le NHS sur les initiatives prendre pendant la pandmie de Covid–19. Chez NHSX, Matthew Gould a eu pour mission d'exploiter la puissance des donnes et de la technologie pour amliorer la prestation des soins de sant. Sa grande exprience aidera Quantexa identifier les marchs et les secteurs d'activit privilgier, ainsi qu' prendre des dcisions en matire de stratgie commerciale.

Sir Jeremy Fleming, ancien directeur du GCHQ et ancien directeur adjoint du MI5, rejoint le comit consultatif, fort de plus de 30 ans d'exprience dans le domaine du renseignement et de la technologie. Sa vaste exprience comprend notamment le dveloppement du Centre national de cyberscurit, o il s'est donn pour mission de faire du Royaume–Uni le pays le plus sr o vivre et entreprendre en ligne. Ayant c"ur de rendre l'utilisation des technologies au sein des gouvernements plus transparente, Sir Fleming aidera Quantexa tirer profit des nouvelles opportunits et faire face aux menaces mergentes.

Nous sommes heureux d'accueillir Ralph Schlosstein, Matthew Gould et Sir Jeremy Fleming au sein de notre comit consultatif , a dclar Vishal Marria, PDG de Quantexa. Leur expertise conjointe dans les domaines de la finance, des soins de sant et de la scurit nationale sera un atout inestimable pour continuer laborer des solutions de pointe en matire d'intelligence dcisionnelle qui rpondent aux besoins du march en constante volution.

La technologie de Quantexa base sur l'IA permet ses clients de protger, d'optimiser et de dvelopper leurs organisations avec efficacit et transparence , a dclar Ralph Schlosstein, ancien PDG d'Evercore et ancien prsident de BlackRock. Je pense que Quantexa a toutes les cartes en main pour saisir les opportunits venir et accrotre sa prsence dans la catgorie mergente qu'est l'intelligence dcisionnelle. Je suis ravi de pouvoir aider l'quipe de direction acclrer sa stratgie de croissance organique et inorganique.

C'est une tape passionnante pour moi que de rejoindre le comit consultatif de Quantexa, ce stade si dcisif de la croissance de l'entreprise , a ajout Matthew Gould. L'approche innovante de Quantexa, qui consiste aider les clients des secteurs priv et public faire des donnes leur principal outil, rvolutionnera la prise de dcision dans de nombreux secteurs d'activit. Je me rjouis de travailler avec l'quipe talentueuse de Quantexa pour interconnecter les donnes et aider les organisations obtenir de meilleurs rsultats.

Sir Jeremy Fleming, ancien directeur du GCHQ, a dclar : Je suis ravi de faire partie d'une entreprise qui est la pointe de l'innovation dans le domaine de l'IA. Je suis impatient de mettre mon exprience au service des capacits exceptionnelles de Quantexa, qui continueront faonner la manire dont ses clients utilisent les donnes pour protger les entreprises et les citoyens .

Avec le soutien de son comit consultatif, Quantexa continuera d'aider les organisations prendre des dcisions oprationnelles fiables grce des solutions innovantes d'intelligence dcisionnelle. Pour en savoir plus sur l'quipe de direction de Quantexa, cliquez ici.

propos de Quantexa"

Pionnire de l'intelligence dcisionnelle, Quantexa est une socit mondiale de logiciels de donnes et d'analyse qui permet aux organisations de prendre des dcisions oprationnelles fiables en rendant les donnes significatives. En utilisant les dernires avances en matire de Big Data et d'IA, la plateforme d'intelligence dcisionnelle de Quantexa rvle les risques cachs et les nouvelles opportunits en fournissant une vision contextuelle et connecte des donnes internes et externes en un seul endroit. Elle rsout des dfis majeurs dans les domaines de la gestion des donnes, de la connaissance du client, de l'intelligence client, de la criminalit financire, des risques, de la fraude et de la scurit, tout au long du cycle de vie client.

La plateforme d'intelligence dcisionnelle de Quantexa amliore la performance oprationnelle avec une prcision accrue de plus de 90 % et une rsolution du modle analytique 60 fois plus rapide que les approches traditionnelles. Fonde en 2016, Quantexa compte aujourd'hui plus de 650 collaborateurs et des milliers d'utilisateurs travaillant avec des milliards de transactions et de points de donnes travers le monde. Les bureaux de la socit sont situs Londres, Dublin, New York, Boston, Washington DC, Toronto, EAU, Malaga, Amsterdam, Luxembourg, Bruxelles, Melbourne, Sydney et Singapour. Pour en savoir plus, suivez–nous sur LinkedIn.

Contact presse :
Contact : Stephanie Crisp, directrice associe et stratge mdia, Fight or Flight""
E–mail : [email protected]""
"
Contact : Adam Jaffe, vice–prsident snior du marketing d'entreprise
Tlphone : +1 609 502 6889""
E–mail : [email protected]""


GLOBENEWSWIRE (Distribution ID 1000841125)

Quantexa ernennt zur Beschleunigung von Wachstumsplänen führende Persönlichkeiten der Branche in seinen Beirat

LONDON, Sept. 25, 2023 (GLOBE NEWSWIRE) — Quantexa, der weltweit fhrende Anbieter von Decision Intelligence (DI)–Lsungen fr den privaten und ffentlichen Sektor, hat heute bekanntgegeben, dass er drei Koryphen der Branche in seinen Beirat berufen hat. Zu diesen Neuzugngen gehren Ralph Schlosstein, ehemaliger CEO von Evercore und ehemaliger President von BlackRock, Matthew Gould, ehemaliger CEO von NHSX, und Sir Jeremy Fleming, ehemaliger Direktor des GCHQ. Diese angesehenen Fhrungskrfte bringen eine Flle von Fachwissen in den Bereichen Finanzen, Gesundheitswesen und nationale Sicherheit zu Quantexa.

Die Erweiterung des Beirats von Quantexa kommt zu einem entscheidenden Zeitpunkt fr das Unternehmen, nach dem Abschluss einer Serie–E–Finanzierungsrunde in Hhe von 129 Mio. USD unter der Leitung von GIC, mit der Quantexa in eine Elitegruppe britischer Technologieunternehmen eintritt, die den Status eines Einhorns erreicht haben. In diesem Jahr wurde auerdem bekannt gegeben, dass Quantexa in den nchsten drei Jahren ber 155 Mio. USD in die globale KI–Branche investieren wird, um Kunden dabei zu helfen, den Einsatz von KI zum Schutz, zur Optimierung und zum Wachstum ihrer Unternehmen voranzutreiben. Bis 2027 werden die weltweiten Investitionen von Quantexa in KI mehr als 250 Mio. USD erreichen.

Ralph Schlosstein, ehemaliger CEO von Evercore und ehemaliger President von BlackRock, bringt seine jahrzehntelange Erfahrung im Investmentbanking in den Beirat von Quantexa ein. In seiner herausragenden Karriere spielte er unter anderem eine strategische Rolle bei der Untersttzung des grten Vermgensverwaltungsunternehmens der Welt beim Brsengang. Der finanzielle Scharfsinn von Herrn Schlosstein wird eine entscheidende Rolle bei der Gestaltung von Unternehmensstrategie–Initiativen spielen.

Matthew Gould, ehemaliger CEO von NHSX, tritt dem Beirat von Quantexa bei, nachdem er zwischen 2010 und 2015 als britischer Botschafter in Israel ttig war. In dieser Zeit half Gould, den UK–Israel Technologies Hub ins Leben zu rufen "" eine Initiative, die in Tel Aviv luft, um Technologiepartnerschaften zwischen britischen und israelischen Unternehmen zu schmieden. In jngster Zeit hat Herr Gould seinen umfangreichen Hintergrund im Gesundheitswesen genutzt, um eine entscheidende Rolle bei der Beratung des NHS zu Initiativen whrend der Covid–19–Pandemie zu spielen. Bei NHSX war Gould fr die Nutzung von Daten und Technologien zur Verbesserung der Gesundheitsversorgung verantwortlich. Das fundierte Fachwissen von Herrn Gould wird Quantexa dabei helfen, die Volkswirtschaften und Branchen zu identifizieren, auf die man sich strategisch konzentrieren sollte, und Entscheidungen zur Geschftsstrategie zu treffen.

Sir Jeremy Fleming, ehemaliger Direktor des GCHQ und ehemaliger stellvertretender Leiter des MI5, tritt dem Beirat mit mehr als 30 Jahren Erfahrung in den Bereichen Geheimdienste und Technologie bei. Zu seinen umfangreichen Erfahrungen gehrt der Aufbau des National Cyber Security Centre, wo er sich dafr einsetzte, das Vereinigte Knigreich zum sichersten Ort zu machen, an dem man online leben und Geschfte machen kann. Sir Fleming setzt sich leidenschaftlich dafr ein, den Einsatz von Technologie durch den Staat transparenter zu machen, und wird die Fhigkeiten von Quantexa bei der Bewltigung neuer Bedrohungen und Chancen verbessern.

"Wir freuen uns, Ralph Schlosstein, Matthew Gould und Sir Jeremy Fleming in unserem Beirat willkommen zu heien", so Vishal Marria, CEO von Quantexa. "Ihr kollektives Fachwissen in den Bereichen Finanzen, Gesundheitswesen und nationale Sicherheit wird von unschtzbarem Wert sein, wenn wir weiterhin hochmoderne Decision Intelligence–Lsungen entwickeln, die den sich wandelnden Anforderungen des Marktes gerecht werden."

"Die KI–gesttzte Technologie von Quantexa ermglicht es seinen Kunden, ihre Unternehmen mit Effizienz und Transparenz zu schtzen, zu optimieren und zu vergrern", so Ralph Schlosstein, ehemaliger CEO von Evercore und ehemaliger President von BlackRock. "Ich glaube, dass Quantexa gut positioniert ist, um die kommenden Chancen zu nutzen und seinen Anteil an der aufstrebenden Kategorie Decision Intelligence zu erhhen. Ich freue mich darauf, das Fhrungsteam dabei zu untersttzen, seine organische und anorganische Wachstumsstrategie zu beschleunigen."

"Es ist eine aufregende Zeit fr mich, dem Beirat von Quantexa in dieser kritischen Wachstumsphase des Unternehmens beizutreten," so Matthew Gould. "Der innovative Ansatz von Quantexa, Kunden aus dem privaten und ffentlichen Sektor dabei zu helfen, Daten zu ihrem wertvollsten Hilfsmittel zu machen, revolutioniert die Entscheidungsfindung in zahlreichen Branchen. Ich freue mich darauf, mit dem talentierten Team von Quantexa zusammenzuarbeiten, um Daten zu verbinden und bessere Ergebnisse fr Unternehmen zu erzielen."

Sir Jeremy Fleming, ehemaliger Direktor des GCHQ, kommentierte dies wie folgt: "Ich bin begeistert, Teil eines Unternehmens zu sein, das an der Spitze der KI–Innovation steht. Ich freue mich darauf, meine Erfahrung mit den beeindruckenden Fhigkeiten von Quantexa zu kombinieren, die die Art und Weise, wie die Kunden von Quantexa Daten zum Schutz von Unternehmen und Brgern nutzen, weiter prgen werden."

Mit Hilfe seines Beirats widmet sich Quantexa weiterhin der Aufgabe, Unternehmen durch innovative Decision Intelligence–Lsungen in die Lage zu versetzen, verlssliche betriebliche Entscheidungen zu treffen. Mehr ber das Fhrungsteam von Quantexa finden Sie hier.

ber Quantexa"

Quantexa ist ein globales Unternehmen fr Daten– und Analysesoftware, das Pionierarbeit im Bereich Decision Intelligence leistet und Unternehmen in die Lage versetzt, vertrauenswrdige betriebliche Entscheidungen zu treffen, indem es Daten Bedeutung verleiht. Mit den neuesten Fortschritten in den Bereichen Big Data und KI deckt die Decision Intelligence–Plattform von Quantexa verborgene Risiken und neue Chancen auf, indem sie eine kontextbezogene, vernetzte Sicht auf interne und externe Daten an einem einzigen Ort bietet. Sie lst die grten Herausforderungen in den Bereichen Datenmanagement, KYC, Customer Intelligence, Finanzkriminalitt, Risiko, Betrug und Sicherheit whrend des gesamten Kundenlebenszyklus.

Die Quantexa Decision Intelligence–Plattform verbessert die operative Leistung mit ber 90 % mehr Genauigkeit und einer 60–mal schnelleren Auflsung des Analysemodells als herkmmliche Anstze. Quantexa wurde 2016 gegrndet und hat heute mehr als 650 Mitarbeiter und Tausende von Nutzern, die mit Milliarden von Transaktionen und Datenpunkten auf der ganzen Welt arbeiten. Das Unternehmen hat Niederlassungen in London, Dublin, New York, Boston, Washington DC, Toronto, den Vereinigten Arabischen Emiraten, Malaga, Amsterdam, Luxemburg, Brssel, Melbourne, Sydney und Singapur. Fr weitere Informationen folgen Sie uns auf LinkedIn.

Medienanfragen:
Kontakt: Stephanie Crisp, Associate Director and Media Strategist, Fight or Flight""
E–Mail: [email protected]""
"
Kontakt: Adam Jaffe, SVP of Corporate Marketing""
Tel.: +1 609 502 6889""
E–Mail: [email protected]""


GLOBENEWSWIRE (Distribution ID 1000841125)

Quantexa Appoints Industry Luminaries to its Advisory Board to Accelerate Growth Plans

LONDON, Sept. 22, 2023 (GLOBE NEWSWIRE) — Quantexa, the global leader in Decision Intelligence (DI) solutions for the private and public sectors, announced today that it has appointed three industry luminaries to its Advisory Board. These hires include Ralph Schlosstein, former CEO of Evercore and former President of BlackRock, Matthew Gould, former CEO of NHSX, and Sir Jeremy Fleming, Former Director of GCHQ. These distinguished leaders bring a wealth of expertise in finance, healthcare, and national security to Quantexa.

The expansion of Quantexa's Advisory Board comes at a pivotal time for the organization, following the completion of a $129 million Series E funding round, led by GIC, where Quantexa joined an elite group of UK tech companies reaching breakout unicorn status. It was also announced this year that Quantexa will invest over $155M in the global AI industry over the next three years to help clients advance the use of AI to protect, optimize, and grow their organizations. By 2027, Quantexa's total global investment in AI will reach more than $250M.

Ralph Schlosstein, former CEO of Evercore and former President of BlackRock, brings decades of experience in investment banking to Quantexa's Advisory Board. His distinguished career includes playing a strategic role in helping the world's largest asset management firm go public. Ralph's financial acumen will play a pivotal role in shaping corporate strategy initiatives.

Matthew Gould, former CEO of NHSX, joins Quantexa's Advisory Board, after serving as the British ambassador to Israel between 2010 and 2015, where Gould helped to launch the UK–Israel Technologies Hub "" an initiative run in Tel Aviv to forge technology partnerships between UK and Israeli companies. More recently, Matthew leveraged his extensive background in healthcare to play a pivotal role in advising NHS on initiatives throughout the Covid–19 pandemic. At NHSX, Gould has been responsible for harnessing the power of data and technology to improve healthcare delivery. Matthew's deep expertise will help Quantexa identify the economies and industries for strategic focus and make decisions on commercial strategy.

Sir Jeremy Fleming, Former Director of GCHQ, and former Deputy Head of MI5, joins the Advisory Board with more than 30 years of experience in intelligence and technology. His extensive background includes developing the National Cyber Security Centre, where he strived to make the UK the safest place to live and do business online. With a passion for making technology use in government more transparent, Sir Fleming will enhance Quantexa's capabilities in addressing emerging threats and opportunities.

“We are pleased to welcome Ralph Schlosstein, Matthew Gould, and Sir Jeremy Fleming to our Advisory Board,” said Vishal Marria, CEO of Quantexa. “Their collective expertise in finance, healthcare, and national security will be invaluable as we continue to develop cutting–edge decision intelligence solutions that address the evolving needs of the market.”

"Quantexa's AI–enabled technology allows its customers to protect, optimize, and grow their organizations with efficiency and transparency," said Ralph Schlosstein, former CEO of Evercore and former President of BlackRock. "I believe Quantexa is well–positioned to capture the opportunities ahead and increase its share of the emerging Decision Intelligence category. I am looking forward to supporting the executive team as they work to accelerate their organic and inorganic growth strategy."

“It's an exciting time for me to be joining Quantexa's Advisory Board, at this critical stage of growth for the company,” said Matthew Gould. “Quantexa's innovative approach to helping customers in the private and public sectors make data their most valuable utility is revolutionizing decision making across multiple industries. I look forward to working alongside the talented team at Quantexa to connect data and drive better outcomes for organizations."

Sir Jeremy Fleming, Former Director of GCHQ commented "I'm thrilled to be part of a company at the forefront of AI innovation. I look forward to combining my experience with Quantexa's impressive capabilities, which will continue to shape how their customers use data to protect businesses and citizens."

With the help of its Advisory Board, Quantexa remains dedicated to empowering organizations to make trusted operational decisions through innovative Decision Intelligence solutions. For more on Quantexa's Leadership team, visit here.

###

About Quantexa"

Quantexa is a global data and analytics software company pioneering Decision Intelligence that empowers organizations to make trusted operational decisions by making data meaningful. Using the latest advancements in big data and AI, Quantexa's Decision Intelligence platform uncovers hidden risk and new opportunities by providing a contextual, connected view of internal and external data in a single place. It solves major challenges across data management, KYC, customer intelligence, financial crime, risk, fraud, and security, throughout the customer lifecycle.

The Quantexa Decision Intelligence Platform enhances operational performance with over 90% more accuracy and 60 times faster analytical model resolution than traditional approaches. Founded in 2016, Quantexa now has more than 650 employees and thousands of users working with billions of transactions and data points across the world. The company has offices in London, Dublin, New York, Boston, Washington DC, Toronto, UAE, Malaga, Amsterdam, Luxembourg, Brussels, Melbourne, Sydney, and Singapore. For more information, follow us on LinkedIn.

Media Inquiries:
C: Stephanie Crisp, Associate Director and Media Strategist, Fight or Flight""
E: [email protected]""
"
C: Adam Jaffe, SVP of Corporate Marketing""
T: +1 609 502 6889""
E: [email protected]""


GLOBENEWSWIRE (Distribution ID 1000840648)

Impulse Dynamics Announces Leadership Changes

MARLTON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure, announced new leadership appointments, including Jason Spees to Chief Executive Officer, Shlomi Nachman to Chairman of the Board, and John Liddicoat, M.D., as a member of the Board of Directors. Spees was recently President and Chief Commercial Officer at Impulse Dynamics and brings a depth of medical device industry experience from commercial leadership roles. Nachman most recently was the Company Group Chairman at Johnson & Johnson, overseeing the Cardiovascular and Specialty Solutions & Vision Group. Liddicoat most recently served as Executive Vice President and President of the Americas Region and Enterprise Technology & Innovation function at Medtronic.

"I am pleased to lead the Impulse Dynamics team, focusing on a strong commercialization strategy and our commitment to an ongoing pace of innovation to change the course of treatment for patients living with heart failure," said Spees. "We find ourselves in a unique position to capitalize on robust clinical data and a lineup of cutting–edge technologies, exemplified by the Integra–D trial featuring the groundbreaking single device that integrates our CCM technology with implantable cardioverter defibrillator (ICD) technology. I look forward to working closely with the board and the leadership team to optimize the company for its next phase of commercial acceleration."

"I am honored to join the board of an organization that has showcased substantial contributions to the advancement of heart failure treatment," said Shlomi Nachman. "Over 64 million people suffer from heart failure, and many of those treated are not experiencing the higher quality of life they deserve. With CCM therapy and its future product pipeline, we are in the exciting position of being able to help millions of these patients to feel better and lead fuller lives," Nachman added. "I'm looking forward to working with the leadership team and the board to ensure a direct path to ongoing innovation and commercial success."

"I've been watching Impulse Dynamics and its technology from the sidelines for many years, and I am excited to now be able to join the team," said Liddicoat. "I look forward to working with a strong leadership team to lead innovation–driven growth as we aim to enhance the standard of care for heart failure patients across the globe."

Jason Spees joined the company as President and Chief Commercial Officer in July 2021. He brings more than two decades of successful leadership roles in the medical device industry. Spees was most recently Senior Vice President of Sales and Marketing for Biotronik in the areas of cardiac rhythm management, cardiovascular intervention, peripheral vascular intervention, diagnostics, and digital health. Prior to Biotronik, Spees was the Chief Commercial Officer of Preventice Solutions, along with multiple leadership positions, including Vice President of Sales for Boston Scientific. He holds a B.S. in Operations Research and Engineering from the United States Air Force Academy and an M.A. in Public Management – Finance from the University of Maryland.

Shlomi Nachman was the Company Group Chairman of Cardiovascular and Specialty Solutions and Visions Group within Johnson & Johnson's Medical Devices sector. Nachman was a member of the Medical Devices Group Operating Committee, where he led a diverse portfolio of six medical device businesses, including Electrophysiology, Neurovascular Intervention, Ear, Nose & Throat, Breast Aesthetics, Optometry and Ophthalmology. Before that, Nachman had various roles with increased scope and responsibilities, including Worldwide President of Biosense Webster and Cordis. His career at Johnson & Johnson spanned over 27 years, comprising multiple leadership positions with a proven track record of success that has recognized the ability to drive growth, innovation, and architect business turnarounds. Additionally, Nachman has accrued deep knowledge in all aspects of medical devices, such as general management, strategy, L&A, finance, product development, operations, sales and marketing, and research and development. Nachman was born in Israel and holds a B.S. in Management and Economics from the Technion Institute, as well as a diploma in electrical engineering from the Amal Technical School.

John Liddicoat brings a history of transformational leadership focused on execution. He spent 16 years at Medtronic, driving the strategic direction and global operations of increasing size and scope, including the Structural Heart, Cardiac Rhythm, and Heart Failure businesses. In his most recent role as Executive Vice President and President of the Americas region and the Enterprise Innovation and Technology function, he was responsible for designing and implementing go–to–market strategies to deliver above–market growth across North and South America. Liddicoat graduated medical school from the University of Chicago, completed a residency in general and cardiothoracic surgery at Johns Hopkins Hospital, and served on the faculty of Harvard Medical School. An innovator and entrepreneur, he has also served as a consultant to venture capital firms and early–stage medical device companies.

About the Optimizer Integra CCM–D System and CCM Therapy

The Optimizer Integra CCM–D System is an investigational device that combines CCM therapy and ICD therapy into one device. This device is being used in an FDA–approved Investigational Device Exemption (IDE) study and is not available for sale in the United States.

Impulse Dynamics currently offers the Optimizer system that is FDA–approved and CE–marked. The Optimizer system delivers CCM therapy "" the company's proprietary technology "" to the heart. CCM therapy has been designed by Impulse Dynamics to improve the heart's contraction, allowing more oxygen–rich blood to be pushed out through the body. CCM therapy is indicated to improve the 6–minute hall walk, quality of life, and functional status of NYHA Class III heart failure patients who remain symptomatic despite guideline–directed medical therapy, are not indicated for CRT, and have a left ventricular ejection fraction ranging from 25 to 45 percent.

CCM therapy delivers non–excitatory electrical pulses from the implantable Optimizer device in a manner designed to improve heart contraction. CCM therapy sends unique electrical pulses to the heart cells during their absolute refractory period. Impulse Dynamics has completed numerous clinical studies, including several randomized controlled trials, and CCM therapy has been published in more than 120 peer–reviewed journal articles.

About Impulse Dynamics

Impulse Dynamics is dedicated to advancing the treatment of heart failure for patients and the healthcare providers who care for them. The company pioneered its proprietary CCM therapy, which uses the Optimizer technology platform to improve quality of life in heart failure patients. CCM therapy is delivered through the Optimizer system, which includes an IPG implanted in a minimally invasive procedure and approved for commercial use in the United States and 44 countries worldwide. More than 9,000 patients have received the therapy as part of clinical trials and real–world use, where it is proven to be safe and effective for heart failure patients with debilitating symptoms who otherwise have few effective options available to them. To learn more, visit www.ImpulseDynamics.com or follow the company on LinkedIn, Twitter, and Facebook.

Forward–Looking Statements

This press release contains forward–looking statements. All statements other than statements of historical facts contained in this press release are forward–looking statements. In some cases, you can identify forward–looking statements by terms such as ""may,'' ""will,'' ""should,'' ""expect,'' ""plan,'' ""anticipate,'' ""could,'' ""intend,'' ""target,'' ""project,'' ""contemplate,'' ""believe,'' ""estimate,'' ""predict,'' ""potential'' or ""continue'' or the negative of these terms or other similar expressions, although not all forward–looking statements contain these words. Forward–looking statements include, but are not limited to, statements concerning potential benefits of CCM therapy, and CCM therapy combined with an ICD delivered via a single device (CCM–D), and the absence of risks associated therewith; the ability for CCM therapy and our products to fill a significant unmet medical need for patients with heart failure; and the short–term and long–term benefits of the Optimizer Integra CCM–D System and CCM therapy in patients with heart failure, as well as to the physicians treating those patients. These forward–looking statements are based on management's current expectations and involve known and unknown risks and uncertainties that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward–looking statements. Other important factors that could cause actual results, performance or achievements to differ materially from those contemplated in this press release include, without limitation: the company's future research and development costs, capital requirements and the company's needs for additional financing; commercial success and market acceptance of CCM therapy; the company's ability to achieve and maintain adequate levels of coverage or reimbursement for Optimizer systems or any future products the company may seek to commercialize; competitive companies and technologies in the industry; the company's ability to expand its indications and develop and commercialize additional products and enhancements to its current products; the company's business model and strategic plans for its products, technologies and business, including its implementation thereof; the company's ability to expand, manage and maintain its direct sales and marketing organization; the company's ability to commercialize or obtain regulatory approvals for CCM therapy and its products, or the effect of delays in commercializing or obtaining regulatory approvals; FDA or other U.S. or foreign regulatory actions affecting us or the healthcare industry generally, including healthcare reform measures in the United States and international markets; the timing or likelihood of regulatory filings and approvals; and the company's ability to establish and maintain intellectual property protection for CCM therapy and products or avoid claims of infringement. The company does not undertake any obligation to update forward–looking statements and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward–looking statements contained herein. These forward–looking statements should not be relied upon as representing the company's views as of any date subsequent to the date of this press release.

###


GLOBENEWSWIRE (Distribution ID 8924737)

Chief Sales Officer von AI-Media präsentiert Untertitelungsinnovation auf der kommenden IBC Broadcast-Messe

BROOKLYN, New York, Sept. 14, 2023 (GLOBE NEWSWIRE) — AI–Media, der fhrende Anbieter von technologiebasierten Lsungen fr Live–Untertitelung, Transkription und bersetzung, freut sich, seine Teilnahme an der IBC Show 2023 anzukndigen, die vom 15. bis 18. September in Amsterdam, Niederlande, stattfindet. Die Veranstaltung verspricht ein Zusammentreffen von Branchenexperten, Vordenkern und innovativen Unternehmen im Bereich der Rundfunk– und Medientechnologie zu werden.

Als weltweit fhrender Anbieter von Untertiteln fr die Rundfunk– und Fernsehbranche ist AI–Media stolz darauf, an dieser einflussreichen Veranstaltung teilzunehmen. Unser Chief Sales Officer, James Ward, wird unsere Delegation anfhren und unser Engagement fr Spitzenleistungen bei der Bereitstellung von Spitzenlsungen fr unsere Kunden und Partner vertreten.

James Ward, Chief Sales Officer von AI–Media, dazu:

"Wir freuen uns, dass wir erneut an der IBC teilnehmen knnen. Diese Messe ist eine auergewhnliche Plattform fr uns, um unsere neuesten Innovationen zu prsentieren und zu zeigen, wie wir die Grenzen des Machbaren in der Broadcast–Branche immer weiter verschieben. Wir freuen uns darauf, mit Branchenfhrern, Kunden und Partnern ins Gesprch zu kommen und unsere Vision fr die Zukunft des Broadcastings zu teilen."

AI–Media wird auf der Veranstaltung mehrere wichtige Broadcast–Lsungen vorstellen, deren Eckpfeiler unsere KI–gesttzte Lsung fr automatische Live–Untertitelung "" LEXI "" ist. LEXI liefert durchgngig Genauigkeitsraten von ber 98 %, erkennt Sprecherwechsel, nutzt KI, um sicherzustellen, dass die Untertitel den Bildschirminhalt nicht unterbrechen, und das alles zu einem Bruchteil der Kosten von menschlichen Untertiteln. Dieses innovative Tool revolutioniert die Untertitelung in Echtzeit und bietet eine kosteneffiziente Lsung, die von den weltweit fhrenden Rundfunkanstalten angenommen wird. AI–Media wird auf dem Stand Live–Demos durchfhren, um diese bahnbrechende Technologie in Aktion zu zeigen.

Das krzlich eingefhrte KI–gesttzte LEXI Captioning Tool Kit wird ebenfalls auf der IBC2023 vorgestellt und umfasst sechs Schlssellsungen, die jeweils fr unterschiedliche Untertitelungsanforderungen konzipiert sind. LEXI Tool Kit verndert die Erstellung von Inhalten und Untertiteln und bietet komplette End–to–End–Lsungen fr Medienunternehmen, Sendeanstalten, Veranstaltungsproduzenten, Bildungseinrichtungen und Content–Ersteller weltweit. Sender knnen die Komponenten des Toolkits je nach ihren geschftlichen Anforderungen kombinieren und auf Lsungen wie Untertitelung, bersetzung, Archivierung und Suche sowie Disaster Recovery zugreifen.

Mit der IP–Videoproduktion an der Spitze der Innovation in der Broadcasting–Landschaft knnen Sender auf AI–Media's ALTA Lsung fr ihre IP–kompatible Closed Captioning– und Untertitel–Encoding–Lsung zu suchen. ALTA untersttzt globale bertragungsstandards wie SMPTE–2110 und MPEG–TS–Eingnge und kann 2110–40, DVB–Untertitel, DVB–TTML, DVB–Teletext und SMPTE 2038 ausgeben. ALTA kann als eigenstndige virtuelle Maschine, als vorkonfiguriertes AMI oder als schlsselfertiger physischer Server bereitgestellt werden und fgt sich so in jeden Produktionsablauf ein. ALTA beherrscht nicht nur mhelos sechs Sprachen pro Instanz, sondern untersttzt auch die Einblendung von Werbehinweisen gem SCTE–35 und SCTE–104. Mit ALTA hilft AI–Media den Sendern, ihre IP–Videobertragungen auf ein neues Niveau der Reichweite und Zugnglichkeit zu heben. Ebenfalls am Stand erhltlich ist unser Angebot an SDI–Hardware–Encodern, einschlielich unseres Encoder Pro (HD492) 1 RU Caption Encoders "" mittlerweile der Broadcast–Standard fr SDI–Encoder.

Wir freuen uns auch, unseren Kunden einen ersten Einblick in unsere aktualisierte LEXI Translate–Lsung zu geben, die die nchste Stufe der sprachlichen Zugnglichkeit in unserem LEXI Tool Kit darstellt. Diese in Krze erscheinende Version zeichnet sich durch eine unbertroffene Genauigkeit bei der Echtzeitbersetzung aus und ermglicht es den Sendern, Inhalte an ein greres Publikum als je zuvor zu verbreiten.

Besuchen Sie AI–Media auf der IBC 2023, 15.–18. September, RAI Amsterdam Convention Centre, Stand Nr. 5.C31. Die Teilnehmer werden aufgefordert, einen Termin mit dem AI–Media–Team zu vereinbaren, um unser Angebot an Komplettlsungen fr die Untertitelung von Sendungen kennenzulernen.

ber AI–Media

Das 2003 in Australien gegrndete Technologieunternehmen AI–Media ist ein weltweit fhrender Anbieter von Lsungen fr Live– und aufgezeichnete Untertitelung, Transkription und bersetzung. Mit seiner KI–gesttzten automatischen Untertitelungslsung LEXI untersttzt das Unternehmen die weltweit fhrenden Rundfunkanstalten, Unternehmen und staatlichen Behrden bei der Gewhrleistung einer hochprzisen, sicheren und kosteneffektiven Untertitelung. LEXI–Untertitel werden ber den Untertitel–Encoder und das iCap Cloud–Netzwerk von AI–Media "" das weltweit grte und sicherste Netzwerk zur Bereitstellung von Untertiteln "" an Millionen von Bildschirmen weltweit geliefert. Weltweit liefert AI–Media monatlich ber 8 Millionen Minuten an Live– und aufgezeichneten Medien. AI–Media wird an der australischen Brse (ASX:AIM) gehandelt. Weitere Informationen finden Sie unter Ai–Media.tv.

Ein Foto zu dieser Ankndigung ist verfgbar unter : https://www.globenewswire.com/NewsRoom/AttachmentNg/976356bd–2ae1–4f56–89ed–437f9da454a2


GLOBENEWSWIRE (Distribution ID 8922473)

Le directeur des ventes chez AI-Media est ravi de présenter une innovation en matière de sous-titrage lors du prochain salon professionnel IBC sur la diffusion

BROOKLYN, État de New York, 14 sept. 2023 (GLOBE NEWSWIRE) — AI–Media, le chef de file des solutions de traduction, de transcription et de sous–titrage en direct s'axant sur la technologie, a le plaisir d'annoncer sa prsence au salon IBC 2023, qui doit avoir lieu du 15 au 18 septembre Amsterdam, aux Pays–Bas. L'vnement promet d'tre un rassemblement d'experts de l'industrie, de leaders d'opinion et d'entreprises innovantes dans le secteur de la diffusion et des technologies mdiatiques.

En tant que leader mondial du sous–titrage pour l'industrie de la diffusion, AI–Media est fire de faire partie de cet vnement d'une grande influence. Notre directeur des ventes, James Ward, dirigera notre dlgation et reprsentera notre engagement envers l'excellence dans la fourniture de solutions de pointe nos clients et partenaires.

James Ward, directeur des ventes d'AI–Media, a dclar :

Nous sommes ravis de faire une nouvelle fois partie du salon IBC. Ce salon professionnel est une plateforme exceptionnelle qui nous permet de prsenter nos dernires innovations et de dmontrer comment nous continuons repousser les frontires du possible dans l'industrie de la diffusion. Nous sommes impatients d'changer avec des leaders de l'industrie, des clients et des partenaires, et de partager notre vision de l'avenir de la diffusion.

AI–Media va prsenter plusieurs solutions de diffusion cls lors de l'vnement, LEXI tant la pierre angulaire de notre solution de sous–titrage automatique en direct optimise par l'IA. LEXI fournit systmatiquement des taux de prcision suprieurs 98 %, identifie les changements de locuteur, utilise l'IA pour garantir que les sous–titres n'interrompent pas le contenu l'cran, et tout cela pour une fraction du cot des sous–titres d'origine humaine. Cet outil innovant est en train de rvolutionner le sous–titrage en temps rel, apportant une solution rentable qui a t adopte par les plus grands diffuseurs du monde. AI–Media organisera des dmonstrations en direct sur le stand pour prsenter cette technologie rvolutionnaire en action.

Le Kit d'outils de sous–titrage LEXI optimis par l'IA rcemment lanc sera galement prsent lors du salon IBC2023, avec six solutions cls, chacune conue pour rpondre aux diffrents besoins du sous–titrage. Le Kit d'outils LEXI transforme la cration de contenu et le sous–titrage, en proposant des solutions de bout en bout compltes pour les socits de mdias, les diffuseurs, les producteurs d'vnements, les tablissements d'enseignement et les crateurs de contenu dans le monde entier. Les diffuseurs peuvent associer et assortir les lments du Kit d'outils en fonction de leurs besoins professionnels, en ayant accs des solutions qui comprennent le sous–titrage, la traduction, l'archivage et la recherche, ainsi que la reprise aprs sinistre.

Avec la production de vido IP l'avant–garde de l'innovation dans le paysage de la diffusion, les diffuseurs peuvent compter sur la solution ALTA d'AI–Media pour leur encodage de sous–titres compatibles IP. ALTA adhre aux normes de diffusion mondiales, notamment les entres SMPTE–2110 et MPEG–TS, et peut produire des sous–titres 2110–40, DVB, DVB TTML, DVB Teletext et SMPTE 2038. ALTA peut s'adapter n'importe quel flux de production car elle peut tre dploye en tant que machine virtuelle autonome, AMI prte l'emploi ou serveur physique cl en main. En plus de grer sans effort six langues par instance, ALTA prend galement en charge l'insertion de signaux publicitaires l'aide de marqueurs SCTE–35 et SCTE–104. Avec ALTA, AI–Media aide les diffuseurs lever leurs diffusions vido par IP vers de nouveaux sommets en termes de porte et d'accessibilit. Notre stand prsentera galement notre gamme d'encodeurs matriels SDI, notamment notre encodeur de sous–titres Encoder Pro (HD492) 1 RU, dsormais synonyme de norme de la diffusion pour les encodeurs SDI.

Nous sommes galement impatients de fournir aux clients un aperu anticip de notre solution LEXI Translate amliore, qui constitue le niveau suprieur d'accessibilit linguistique au sein de notre Kit d'outils LEXI. Cette version bientt disponible offre une prcision ingale de traduction en temps rel, ce qui permet aux diffuseurs de distribuer le contenu une audience plus vaste que jamais auparavant.

Rejoignez AI–Media lors du salon IBC 2023, du 15 au 18 septembre, au Centre de conventions et d'expositions RAI Amsterdam, stand n 5.C31. Les participants sont encourags rserver une rencontre avec l'quipe AI–Media qui leur fera dcouvrir notre gamme de solutions de sous–titrage pour la diffusion de bout en bout.

propos d'AI–Media

Fonde en Australie en 2003, la socit technologique AI–Media est un leader mondial des solutions de traduction, de transcription et de sous–titrage enregistrs et en direct. La socit aide les principaux diffuseurs, entreprises et organismes gouvernementaux du monde assurer des sous–titrages de haute prcision, scuriss et rentables via sa solution de sous–titrage automatique LEXI optimise par l'IA. Des sous–titres LEXI sont livrs sur des millions d'cran travers le monde grce la gamme d'encodeurs de sous–titrage d'AI–Media et son rseau iCap Cloud "" le rseau de livraison de sous–titres le plus grand et le plus scuris au monde. l'chelle mondiale, AI–Media livre plus de 8 millions de minutes de contenu multimdia en direct et enregistr chaque mois. AI–Media est cote la bourse australienne (ASX : AIM). Pour de plus amples informations, rendez–vous sur le site AI–Media.tv.

Une photo accompagnant cette annonce est disponible sur https://www.globenewswire.com/NewsRoom/AttachmentNg/976356bd–2ae1–4f56–89ed–437f9da454a2


GLOBENEWSWIRE (Distribution ID 8922473)

Diretor de Vendas da AI-Media Animado em Mostrar a Inovação de Legendagem na Próxima IBC Broadcast Tradeshow

BROOKLYN, N.Y., Sept. 14, 2023 (GLOBE NEWSWIRE) — A AI–Media, lder em solues de legendagem, legendagem oculta, transcrio e traduo ao vivo com base em tecnologia, tem o prazer de anunciar sua presena na IBC Broadcast Tradeshow a ser realizada entre 15 e 18 de setembro em Amsterd, Pases Baixos. O evento promete ser um encontro de especialistas, lderes de pensamento e empresas inovadoras do setor de tecnologia de transmisso e mdia.

Como lder global em legendagem e legendagem oculta para a indstria de transmisso, a AI–Media tem orgulho de fazer parte deste evento influente. Nosso Diretor de Vendas, James Ward, liderar nossa delegao e representar o nosso compromisso com a excelncia no fornecimento de solues de ponta para nossos clientes e parceiros.

O Diretor de Vendas da AI–Media, James Ward, disse:

um grande prazer fazer parte da IBC Broadcast Tradeshow mais uma vez. Esta feira uma plataforma excepcional para mostrarmos nossas ltimas inovaes e demonstrarmos como continuamos a expandir os limites do que possvel no setor de transmisso. Estamos empolgados em nos envolver com lderes, clientes e parceiros do setor e compartilhar nossa viso para o futuro da transmisso.”

A AI–Media mostrar vrias solues–chave de transmisso no evento, com a nossa base fundamental, nossa soluo de legendagem automtica ao vivo com tecnologia AI "" LEXI. A LEXI oferece consistentemente taxas de preciso de mais de 98%, identifica alteraes no falante, usa IA para garantir que as legendas no interrompam o contedo na tela e tudo por uma frao do custo da legendagem humana. Esta ferramenta inovadora est revolucionando a legendagem em tempo real, fornecendo uma soluo econmica que est sendo adotada pelas principais emissoras do mundo. A AI–Media far demonstraes ao vivo no estande mostrando essa tecnologia inovadora em ao.

O recm–lanado LEXI Captioning Tool Kit, alimentado por IA, tambm ser apresentado na IBC2023, com seis solues principais, todas projetadas para atender as diferentes necessidades da legendagem. O LEXI Tool Kit transforma a criao e legendagem de contedo, oferecendo solues completas de ponta a ponta para empresas de mdia, emissoras, produtores de eventos, instituies educacionais e criadores de contedo em todo o mundo. As emissoras podem misturar e combinar os componentes do Tool Kit para atender s necessidades dos seus negcios, acessando solues, incluindo legendagem, traduo, arquivamento e pesquisa, e recuperao de desastres.

Com a produo de vdeo IP na vanguarda da inovao no cenrio de transmisso, as emissoras podem procurar a soluo ALTA da AI–Media para codificao de legendagem e legendagem oculta compatvel com IP. A ALTA compatvel com padres de transmisso globais, incluindo SMPTE–2110, entradas MPEG–TS e com sada 2110–40, legendas DVB, DVB TTML, DVB Teletext e SMPTE 2038. Implantvel como uma mquina virtual autnoma, uma AMI pr–definida ou um servidor fsico pronto para uso, a ALTA pode se encaixar em qualquer fluxo de trabalho de produo. Alm de lidar sem esforo com seis idiomas por instncia, a ALTA tambm compatvel com insero de dicas de publicidade com SCTE–35 e SCTE–104. Com a ALTA, a AI–Media est ajudando as emissoras a elevar suas transmisses de vdeo IP a novos patamares de alcance e acessibilidade. Tambm estar disponvel no estande nossa linha de codificadores de hardware SDI, incluindo nosso codificador de legenda RU Encoder Pro (HD492) 1 – agora sinnimo de padro de transmisso para codificadores SDI.

Tambm estamos muito contentes de fornecer aos clientes uma viso antecipada da nossa soluo LEXI Translate atualizada, o prximo nvel de acessibilidade de idiomas do nosso LEXI Tool Kit. Esta verso, a ser lanada em breve, tem uma preciso inigualvel na traduo em tempo real, permitindo que as emissoras distribuam contedo para um pblico mais amplo do que nunca.

Junte–se AI–Media na IBC 2023, de 15 a 18 de setembro, RAI Amsterdam Convention Centre, Estande #5.C31. Os participantes podem marcar uma reunio com a equipe da AI–Media para descobrir sua gama de solues de legendagem de transmisso.

Sobre a AI–Media

Fundada na Austrlia em 2003, a empresa de tecnologia AI–Media lder global de solues de legendagem transcrio e traduo ao vivo e gravadas. A empresa ajuda as principais emissoras, empresas e agncias governamentais do mundo a garantir alta preciso, segurana e custo–benefcio por meio da sua soluo de legendagem automtica LEXI com tecnologia de IA. As legendas LEXI so entregues a milhes de telas em todo o mundo atravs da gama de codificadores de legendas da AI–Media e sua iCap Cloud Network "" a maior e mais segura rede de entrega de legendas do mundo. A AI–Media entrega mais de 8 milhes de minutos de mdia ao vivo e gravada mensalmente em todo o mundo. A AI–Media negociada na Bolsa de Valores da Austrlia (ASX: AIM). Para mais informao, visite AI–Media.tv.

Foto deste comunicado disponvel em https://www.globenewswire.com/NewsRoom/AttachmentNg/976356bd–2ae1–4f56–89ed–437f9da454a2


GLOBENEWSWIRE (Distribution ID 8922473)

Chief Sales Officer of AI-Media Excited to Showcase Subtitling Innovation at Upcoming IBC Broadcast Tradeshow

BROOKLYN, N.Y., Sept. 13, 2023 (GLOBE NEWSWIRE) — AI–Media, the leader in technology–driven live captioning & subtitling, transcription, and translation solutions, is excited to announce its presence at the IBC Show 2023, scheduled to take place from 15th "" 18th September in Amsterdam, NE. The event promises to be a gathering of industry experts, thought leaders, and innovative companies in the broadcast and media technology sector.

As the global leader in captioning and subtitling for the broadcast industry, AI–Media is proud to be part of this influential event. Our Chief Sales Officer, James Ward, will lead our delegation and represent our commitment to excellence in delivering cutting–edge solutions to our clients and partners.

AI–Media's Chief Sales Officer, James Ward said:

“We are delighted to participate at the IBC show once again. This tradeshow is an exceptional platform for us to showcase our latest innovations and demonstrate how we continue to push the boundaries of what's possible in the broadcast industry. We're excited to engage with industry leaders, customers, and partners, and to share our vision for the future of broadcasting.”

AI–Media will be showcasing several key broadcast solutions at the event, the cornerstone of which is our AI–Powered live automatic captioning solution "" LEXI. LEXI consistently delivers accuracy rates of over 98%, identifies speaker changes, uses AI to ensure captions don't interrupt onscreen content and all at a fraction of the cost of human captions. This innovative tool is revolutionizing real–time captioning, providing a cost–effective solution that has been embraced by the world's leading broadcasters. AI–Media will be conducting live demos at the booth to display this groundbreaking technology in action.

The recently launched AI–powered LEXI Captioning Tool Kit will also be featured at IBC2023, featuring six key solutions each designed to address different captioning needs. LEXI Tool Kit transforms content creation and captioning, offering complete end–to–end solutions for media companies, broadcasters, event producers, educational institutions, and content creators worldwide. Broadcasters can mix and match the Tool Kit components to suit their business needs, accessing solutions including captioning, translation, archiving & search and disaster recovery.

With IP video production at the forefront of innovation in the broadcasting landscape; broadcasters can look to AI–Media's ALTA solution for their IP compatible closed captioning and subtitling encoding solution. ALTA supports global broadcast standards including SMPTE–2110, MPEG–TS inputs, and can output 2110–40, DVB subtitles, DVB TTML, DVB Teletext and SMPTE 2038. Deployable as a standalone virtual machine, a pre–packaged AMI or turnkey physical server, ALTA can fit into any production workflow. Along with effortlessly handling six languages per instance, ALTA also supports the insertion of advertising cues using SCTE–35 and SCTE–104. With ALTA, AI–Media is helping broadcasters elevate their IP video broadcasts to new heights of reach and accessibility. Also available at the booth will be our range of SDI Hardware Encoders, including our Encoder Pro (HD492) 1 RU caption encoder – now synonymous as the broadcast standard for SDI encoders.

We're also excited to provide customers with an early look at our upgraded LEXI Translate solution, which is the next level of language accessibility within our LEXI Tool Kit. This soon to be released version boasts unmatched accuracy in real–time translation, allowing broadcasters to distribute content to a wider audience than ever before.

Join AI–Media at IBC 2023, September 15–18, RAI Amsterdam Convention Centre, Booth #5.C31. Attendees are encouraged to book a meeting with the AI–Media team to discover our range of end–to–end broadcast captioning solutions.

About AI–Media

Founded in Australia in 2003, technology company AI–Media is a global leader in live and recorded captioning, transcription and translation solutions. The company helps the world's leading broadcasters, enterprises and government agencies ensure high accuracy, secure and cost–effective captioning via its AI–powered LEXI automatic captioning solution. LEXI captions are delivered to millions of screens worldwide via AI–Media's range of captioning encoders and its iCap Cloud Network "" the world's largest, most secure caption delivery network. Globally, AI–Media delivers over 8 million minutes of live and recorded media monthly. AI–Media trades on the Australian Stock Exchange (ASX:AIM). For more information, please visit AI–Media.tv.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/976356bd–2ae1–4f56–89ed–437f9da454a2


GLOBENEWSWIRE (Distribution ID 8921516)